Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

Breast cancer (BC) is the most common cause of cancer-related death in women worldwide. Therapies targeting molecular pathways altered in BC had significantly enhanced treatment options for BC over the last decades, which ultimately improved the lives of millions of women worldwide. Among various mo...

Full description

Bibliographic Details
Main Authors: Navid Sobhani, Anne Fassl, Giuseppina Mondani, Daniele Generali, Tobias Otto
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cells
Subjects:
breast cancer
FGFR
CDK4
CDK6
inhibitor
therapy resistance
Online Access:https://www.mdpi.com/2073-4409/10/2/293

Similar Items

Similar Items